 |
Anthos Therapeutics
Last updated: October 09, 2024
CEO John Glasspool
USA | Funding: $250M (+)
Website: https://www.anthostherapeutics.com/
Anthos Therapeutics is a clinical-stage biopharmaceutical company developing and commercializing innovative therapies for high-risk cardiovascular patients.
Website: https://www.anthostherapeutics.com/
Anthos Therapeutics is a clinical-stage biopharmaceutical company developing and commercializing innovative therapies for high-risk cardiovascular patients.
